RecruitingNCT05988879

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

A Clinical Research on Functional Cure Strategies for Hepatitis B Among HIV/HBV Co-infected Patients in China


Sponsor

Guangzhou 8th People's Hospital

Enrollment

60 participants

Start Date

Aug 2, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Evaluate the potential of ART combined with interferon therapy to achieve functional cure of hepatitis B in HIV/HBV co-infected patients


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a combination approach — including newer antiviral drugs targeting hepatitis B — can achieve a "functional cure" of hepatitis B in people who are living with both HIV and hepatitis B, and who are already on HIV antiretroviral therapy. **You may be eligible if...** - You are between 18 and 65 years old - You have confirmed HIV-1 infection - You have had hepatitis B surface antigen (HBsAg) positive for more than 6 months (chronic hepatitis B) - You have been on HIV antiretroviral therapy for at least 1 year **You may NOT be eligible if...** - You are not co-infected with both HIV and hepatitis B - You have not been on antiretroviral therapy for at least a year - You are outside the 18-65 age range Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPeginterferon alfa-2b Injection

The pegylated interferon α-2b injection is administered subcutaneously at a dose of 180ug once a week.


Locations(1)

Guangzhou Eighth People's Hospital, Guangzhou Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05988879


Related Trials